WST WEST PHARMACEUTICAL SERVICE...

NYSE westpharma.com


$ 299.00 $ -9.78 (-3.18 %)    

Friday, 24-Oct-2025 17:51:25 EDT
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 297.47
$ 307.94
$ 296.02 x 9
$ 305.28 x 5
$ 297.20 - $ 310.69
$ 187.09 - $ 348.05
819,464
na
21.4B
$ 1.05
$ 43.52
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-23-2025 09-30-2025 10-Q
2 07-24-2025 06-30-2025 10-Q
3 04-24-2025 03-31-2025 10-Q
4 02-18-2025 12-31-2024 10-K
5 10-24-2024 09-30-2024 10-Q
6 07-25-2024 06-30-2024 10-Q
7 04-25-2024 03-31-2024 10-Q
8 02-20-2024 12-31-2023 10-K
9 10-26-2023 09-30-2023 10-Q
10 07-27-2023 06-30-2023 10-Q
11 04-27-2023 03-31-2023 10-Q
12 02-21-2023 12-31-2022 10-K
13 10-27-2022 09-30-2022 10-Q
14 07-28-2022 06-30-2022 10-Q
15 04-28-2022 03-31-2022 10-Q
16 02-22-2022 12-31-2021 10-K
17 10-28-2021 09-30-2021 10-Q
18 07-30-2021 06-30-2021 10-Q
19 04-30-2021 03-31-2021 10-Q
20 02-23-2021 12-31-2020 10-K
21 10-23-2020 09-30-2020 10-Q
22 07-24-2020 06-30-2020 10-Q
23 04-24-2020 03-31-2020 10-Q
24 02-24-2020 12-31-2019 10-K
25 10-29-2019 09-30-2019 10-Q
26 07-29-2019 06-30-2019 10-Q
27 05-08-2019 03-31-2019 10-Q
28 02-28-2019 12-31-2018 10-K
29 10-30-2018 09-30-2018 10-Q
30 07-31-2018 06-30-2018 10-Q
31 05-08-2018 03-31-2018 10-Q
32 02-26-2018 12-31-2017 10-K
33 10-31-2017 09-30-2017 10-Q
34 08-01-2017 06-30-2017 10-Q
35 05-05-2017 03-31-2017 10-Q
36 02-28-2017 12-31-2016 10-K
37 10-31-2016 09-30-2016 10-Q
38 08-01-2016 06-30-2016 10-Q
39 05-06-2016 03-31-2016 10-Q
40 02-26-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ubs-maintains-buy-on-west-pharmaceutical-servs-raises-price-target-to-355

UBS analyst John Sourbeer maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $320 to...

 keybanc-maintains-overweight-on-west-pharmaceutical-servs-raises-price-target-to-350

Keybanc analyst Paul Knight maintains West Pharmaceutical Servs (NYSE:WST) with a Overweight and raises the price target fro...

 evercore-isi-group-maintains-outperform-on-west-pharmaceutical-servs-raises-price-target-to-390

Evercore ISI Group analyst Daniel Markowitz maintains West Pharmaceutical Servs (NYSE:WST) with a Outperform and raises the ...

 oil-stocks-rally-on-trumps-russia-sanctions-whats-moving-markets-thursday

Energy markets dominated headlines Thursday as a fresh wave of U.S. sanctions targeting Russia's oil giants sparked a sharp...

 west-pharma-soars-after-q3-beat-lifts-outlook-on-glp-1-demand

West Pharmaceutical posts Q3 earnings of $1.96 per share and raises 2025 guidance, driven by GLP-1 demand and strong HVP compon...

 west-pharmaceutical-servs-raises-fy2025-adj-eps-guidance-from-665-685-to-706-711-vs-677-est-raises-fy2025-sales-guidance-from-3040b-3060b-to-3060b-3070b-vs-3050b-est

West Pharmaceutical Servs (NYSE:WST) raises FY2025 Adj EPS guidance from $6.65-$6.85 to $7.06-$7.11 vs $6.77 analyst estimate. ...

 west-pharmaceutical-servs-raises-fy2025-gaap-eps-guidance-from-636-656-to-675-680-vs-653-est

West Pharmaceutical Servs (NYSE:WST) raises FY2025 GAAP EPS guidance from $6.36-$6.56 to $6.75-$6.80 vs $6.53 analyst estimate..

 west-pharmaceutical-servs-q3-adj-eps-196-beats-168-estimate-sales-804600m-beat-787929m-estimate

West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $1.96 per share which beat the analyst consensus estimate o...

 barclays-maintains-equal-weight-on-west-pharmaceutical-servs-raises-price-target-to-275

Barclays analyst Luke Sergott maintains West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight and raises the price target...

 looking-into-west-pharmaceutical-servss-recent-short-interest

West Pharmaceutical Servs's (NYSE: WST) short interest as a percent of float has risen 9.25% since its last report. Accordi...

 rothschild--co-initiates-coverage-on-west-pharmaceutical-servs-with-buy-rating-announces-price-target-of-311

Rothschild & Co analyst Jamie Clark initiates coverage on West Pharmaceutical Servs (NYSE:WST) with a Buy rating and ann...

 thermo-fisher-baker-hughes-and-iqvia-holdings-are-among-top-10-large-cap-gainers-last-week-july-21-july-25-are-the-others-in-your-portfolio

Medpace, ICON, and West Pharma led last week's large-cap rally, driven by strong earnings beats and upgraded guidance.

 ubs-maintains-buy-on-west-pharmaceutical-servs-raises-price-target-to-320

UBS analyst John Sourbeer maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $285 to...

 evercore-isi-group-maintains-outperform-on-west-pharmaceutical-servs-raises-price-target-to-350

Evercore ISI Group analyst Daniel Markowitz maintains West Pharmaceutical Servs (NYSE:WST) with a Outperform and raises the ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION